search
Back to results

Emergent Multi-Class Imitation Training (EMIT)

Primary Purpose

Autism Spectrum Disorder

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Emergent Multi-Class Imitation Training
Sponsored by
Rutgers, The State University of New Jersey
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Autism Spectrum Disorder

Eligibility Criteria

12 Months - 6 Years (Child)All SexesAccepts Healthy Volunteers

Inclusion Criteria: Diagnosis of autism spectrum disorder Age 5 or under Maximum score of 40 on Motor Vocal Imitation Assessment Maximum raw score of 36 on Peabody Picture Vocabulary Test-5 Demonstrates identity matching above chance levels Exclusion Criteria: Diagnosis of intellectual disability Diagnosis of certain conditions that impact motor function (e.g., cerebral palsy) Visual impairment Hearing impairment

Sites / Locations

  • Rutgers UniversityRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Other

Arm Label

EMIT Intervention

Waitlist Control

Arm Description

Immediate access to EMIT intervention

Delayed access to EMIT intervention

Outcomes

Primary Outcome Measures

Probe performance
Correct responding to probe trials (novel targets)

Secondary Outcome Measures

Motor Vocal Imitation Assessment
Performance on Motor Vocal Imitation Assessment

Full Information

First Posted
April 5, 2023
Last Updated
April 27, 2023
Sponsor
Rutgers, The State University of New Jersey
search

1. Study Identification

Unique Protocol Identification Number
NCT05849376
Brief Title
Emergent Multi-Class Imitation Training
Acronym
EMIT
Official Title
A Pilot Investigation of Emergent Multi-Class Imitation Training (EMIT)
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Recruiting
Study Start Date
March 27, 2022 (Actual)
Primary Completion Date
August 31, 2024 (Anticipated)
Study Completion Date
August 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Rutgers, The State University of New Jersey

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The goals of this project are to (a) incorporate empirical findings on imitation training and learning in autistic children into a comprehensive protocol for Applied Behavior Analysis practitioners designed to rapidly facilitate generalized imitation called Emergent Multi-Class Imitation Training (EMIT), and (b) collect pilot data on the efficacy of EMIT with a small sample of autistic children. EMIT will incorporate several features that are grounded in prior research including: (a) evidence-based procedures for establishing trained matching relations (a pre-requisite to generalized imitation), (b) concurrent training of different response types (e.g., motor imitation, object imitation, vocal imitation) to address restricted generalization, (c) multiple manipulative object imitation training, (d) evidence-based procedures for remediating slow acquisition, and (e) frequent tests for the emergence of generalized imitation. EMIT will be the first protocol designed for clinical use that reflects research findings on imitation learning spanning almost five decades.
Detailed Description
Using findings from prior research, the investigators will design a manualized training protocol (EMIT) for establishing generalized imitation in autistic children that supervised behavior therapists can implement with a high degree of fidelity. The EMIT protocol will serve as a guide for behavior therapists to help them deliver high-quality, empirically derived imitation training to autistic children. The investigators will conduct a small pilot study to evaluate the effects of EMIT on the emergence of generalized imitation with young autistic children. Single-case experimental design and a 2x2 group design will be used. A multiple baseline across participants design is a single-case design that is common in imitation research with this population. In short, the start of the intervention is stagged across participants to systematically assess the effects of the intervention on each participant's behavior. In this experiment, confirmation that EMIT is responsible for any observed effects will be obtained when changes in each participant's behavior (i.e., correct imitation of novel responses) occur when, and only when, the intervention is introduced. The 2x2 design entails the assignment of participants to an intervention group and a waitlist control group. Participants will be matched across the two groups using the scores and information obtained during the screening process. Participants assigned to the EMIT group will receive the intervention immediately. Participants in the waitlist control group will begin participating in the research sessions when their assigned matched study participant has completed his/her participation in the sessions.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Autism Spectrum Disorder

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
10 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
EMIT Intervention
Arm Type
Experimental
Arm Description
Immediate access to EMIT intervention
Arm Title
Waitlist Control
Arm Type
Other
Arm Description
Delayed access to EMIT intervention
Intervention Type
Behavioral
Intervention Name(s)
Emergent Multi-Class Imitation Training
Intervention Description
Sessions will be conducted in a room with minimal distractions containing a table, two chairs, a timer, and 3-4 highly preferred (HP) items identified by preference assessments.A minimum of 10 sessions per week will be distributed across at least 3 days per week. Each session will take 20-25 min to conduct. Each session will consist of the instructor presenting imitation training trials and probe trials. During baseline sessions, participants will not receive rewards for correct imitation. During training, participants will receive rewards for correct imitation and evidence-based teaching strategies that are commonly employed in ABA therapy will be used to help participants learn how to imitate new responses. Novel probe trials will be embedded throughout all sessions to continuously evaluate the emergence of generalized imitation. When participants can consistently imitate novel probe responses, the intervention will conclude.
Primary Outcome Measure Information:
Title
Probe performance
Description
Correct responding to probe trials (novel targets)
Time Frame
Approximately 3x per week throughout participant's EMIT intervention, approximately 3-6 months
Secondary Outcome Measure Information:
Title
Motor Vocal Imitation Assessment
Description
Performance on Motor Vocal Imitation Assessment
Time Frame
Pre-Intervention and Post-Intervention (within 2 weeks of intervention completion)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
12 Months
Maximum Age & Unit of Time
6 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Diagnosis of autism spectrum disorder Age 5 or under Maximum score of 40 on Motor Vocal Imitation Assessment Maximum raw score of 36 on Peabody Picture Vocabulary Test-5 Demonstrates identity matching above chance levels Exclusion Criteria: Diagnosis of intellectual disability Diagnosis of certain conditions that impact motor function (e.g., cerebral palsy) Visual impairment Hearing impairment
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Meghan A Deshais, Ph.D.
Phone
860-942-4453
Email
m.deshais@rutgers.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Meghan A Deshais, Ph.D.
Organizational Affiliation
Rutgers University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Rutgers University
City
New Brunswick
State/Province
New Jersey
ZIP/Postal Code
08901
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Meghan A Deshais, Ph.D.
Phone
860-942-4453
Email
m.deshais@rutgers.edu

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Emergent Multi-Class Imitation Training

We'll reach out to this number within 24 hrs